Published :
Tables : 56
Figures : 50
Category : Healthcare
No. of Pages : 223
Report Code : HC-U3360
Platelet Rich Plasma Market is estimated to value over USD 900 million by 2028 end with a CAGR of over 12.5% during the forecast period 2022 to 2028. Blood is largely a liquid (called plasma), but it also contains small solid components (red cells, white cells, and platelets). One of the most important functions of platelets is to clot blood. As well as proteins called growth factors, platelets also contain hundreds of other substances that are crucial to the healing process. PRP is plasma containing many more platelets than blood typically contains. Growth factors are concentrated in higher concentrations in platelets than in the usual concentrations. The first step in developing a PRP preparation involves obtaining blood from a patient. A process called centrifugation separates the platelets from other blood cells and increases their concentration. Following this, the platelets will be injected into the injured area. At least seven growth factors are found in platelet rich plasma (PRP). It can be used to treat chronic tendon injuries, acute ligament and muscle injuries, surgery, knee arthritis, fractures, and discomfort, among other conditions. The usage of PRP in orthopaedics is predicted to rise throughout the projection period. Acute sports injuries, such as muscular strains, are increasingly being treated using PRP. PRP is becoming more popular, however its real usefulness has yet to be determined. As a result, PRP is frequently utilised in surgery to repair injured knee ligaments like the anterior cruciate ligament (ACL). PRP aids in the rapid healing of tissue following surgical treatments. Several research studies are under underway to determine the efficacy of PRP in different therapy areas, such as herniated discs and hair loss. Because of its increased availability and capacity to speed up recovery, PRP is now frequently used in a variety of therapeutic fields. Additionally, this treatment has the potential to cut the financial expenditures of typical medical treatments, while it cannot completely replace many vital traditional therapies. FutureWise Market Research has instantiated a report that provides an intricate analysis of Platelet Rich Plasma Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market. According to the research study conducted by FutureWise research analysts, the Platelet Rich Plasma Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical. Major players included in the Platelet Rich Plasma Market: • T-Biotechnology (T-LAB) • Arthrex, Inc • Terumo BCT, Inc • EmCyte Corporation • DePuy Synthes • Zimmer Biomet • Stryker • Glofinn Oy • DR. PRP America, LLC. (Note: The list of the major players will be updated with the latest market scenario and trends) Platelet Rich Plasma Market Segmentation: By Type Pure Platelet-rich Plasma Leukocyte Platelet-rich Plasma Pure Platelet-rich Fibrin Leukocyte Platelet-rich Fibrin By Origin Autologous Platelet-rich Plasma Allogeneic Platelet-rich Plasma Homologus Platelet-rich Plasma By Application • Cosmetic Surgery o Skin Care o Hair Care • Orthopedic Surgery • Ophthalmic Surgery • Dentistry • Cardiac Surgery • Neurosurgery • Other Indications By Indication Stages • Cosmetic Surgery o Skin Care - Stage I, Stage II, Stage III, Stage IV • Skin Ulcers o Diabetic Foot Ulcer - Stage I, Stage II, Stage III, Stage IV o Pressure Ulcer – Stage I, Stage II, Stage III, Stage IV o Venous Insufficiency - Stage I, Stage II, Stage III o Atherosclerosis – Stage I, Stage II, Stage III o Hair Care • Stage I • Stage II • Stage III • Stage IV • Orthopedic Surgery o Stage I o Stage II o Stage III o Stage IV • Ophthalmic Surgery o Stage I o Stage II o Stage III o Stage IV • Dentistry o Stage I o Stage II o Stage III o Stage IV • Cardiac Surgery o Stage I o Stage II o Stage III o Stage IV • Neurosurgery o Stage I o Stage II o Stage III o Stage IV By End-User Physician's office/Private Practice Hospitals Orthopedic Clinics Ophthalmic Clinics Cosmetic/Dermatology/Trichology Clinics Academic & Research Institutes By Region • North America • Latin America • Europe • Asia-Pacific • Middle East and Africa Platelet Rich Plasma Market Sample Video: FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the global platelet rich plasma market by type, by origin, by application, by indication stages, by end user and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Blood is largely a liquid (called plasma), but it also contains small solid components (red cells, white cells, and platelets). One of the most important functions of platelets is to clot blood. As well as proteins called growth factors, platelets also contain hundreds of other substances that are crucial to the healing process. PRP is plasma containing many more platelets than blood typically contains. Growth factors are concentrated in higher concentrations in platelets than in the usual concentrations. The first step in developing a PRP preparation involves obtaining blood from a patient. A process called centrifugation separates the platelets from other blood cells and increases their concentration. Following this, the platelets will be injected into the injured area.
At least seven growth factors are found in platelet rich plasma (PRP). It can be used to treat chronic tendon injuries, acute ligament and muscle injuries, surgery, knee arthritis, fractures, and discomfort, among other conditions. The usage of PRP in orthopaedics is predicted to rise throughout the projection period. Acute sports injuries, such as muscular strains, are increasingly being treated using PRP. PRP is becoming more popular, however its real usefulness has yet to be determined. As a result, PRP is frequently utilised in surgery to repair injured knee ligaments like the anterior cruciate ligament (ACL). PRP aids in the rapid healing of tissue following surgical treatments.
Several research studies are under underway to determine the efficacy of PRP in different therapy areas, such as herniated discs and hair loss. Because of its increased availability and capacity to speed up recovery, PRP is now frequently used in a variety of therapeutic fields. Additionally, this treatment has the potential to cut the financial expenditures of typical medical treatments, while it cannot completely replace many vital traditional therapies.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Platelet Rich Plasma Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Platelet Rich Plasma Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.
Major players included in the Platelet Rich Plasma Market:
• T-Biotechnology (T-LAB) • Arthrex, Inc • Terumo BCT, Inc • EmCyte Corporation • DePuy Synthes • Zimmer Biomet • Stryker • Glofinn Oy • DR. PRP America, LLC. (Note: The list of the major players will be updated with the latest market scenario and trends)
Platelet Rich Plasma Market Segmentation:
By Type
By Origin
By Application • Cosmetic Surgery o Skin Care o Hair Care • Orthopedic Surgery • Ophthalmic Surgery • Dentistry • Cardiac Surgery • Neurosurgery • Other Indications
By Indication Stages • Cosmetic Surgery o Skin Care - Stage I, Stage II, Stage III, Stage IV • Skin Ulcers o Diabetic Foot Ulcer - Stage I, Stage II, Stage III, Stage IV o Pressure Ulcer – Stage I, Stage II, Stage III, Stage IV o Venous Insufficiency - Stage I, Stage II, Stage III o Atherosclerosis – Stage I, Stage II, Stage III o Hair Care • Stage I • Stage II • Stage III • Stage IV • Orthopedic Surgery o Stage I o Stage II o Stage III o Stage IV • Ophthalmic Surgery o Stage I o Stage II o Stage III o Stage IV • Dentistry o Stage I o Stage II o Stage III o Stage IV • Cardiac Surgery o Stage I o Stage II o Stage III o Stage IV • Neurosurgery o Stage I o Stage II o Stage III o Stage IV
By End-User
By Region • North America • Latin America • Europe • Asia-Pacific • Middle East and Africa
Platelet Rich Plasma Market Sample Video:
FutureWise Key Takeaways:
• Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth
Objectives of the Study:
• To provide with an exhaustive analysis on the global platelet rich plasma market by type, by origin, by application, by indication stages, by end user and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions
Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Platelet Rich Plasma Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Platelet Rich Plasma Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Platelet Rich Plasma Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Platelet Rich Plasma Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Pure Platelet-rich Plasma 7.2. Leukocyte Platelet-rich Plasma 7.3. Pure Platelet-rich Fibrin 7.4. Leukocyte Platelet-rich Fibrin 8. Platelet Rich Plasma Market, By Origin Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Autologous Platelet-rich Plasma 8.2. Allogeneic Platelet-rich Plasma 8.3. Homologous Platelet-rich Plasma 9. Platelet Rich Plasma Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Cosmetic Surgery 9.1.1. Skin Care 9.1.2. Hair Care 9.2. Orthopedic Surgery 9.3. Ophthalmic Surgery 9.4. Dentistry 9.5. Cardiac Surgery 9.6. Neurosurgery 9.7. Other Indications 10. Platelet Rich Plasma Market, By Indication Stages Historical Analysis and Forecast 2022-2028 (USD Million) 10.1. Cosmetic Surgery 10.1.1. Skin Care - Stage I, Stage II, Stage III, Stage IV 10.1.1.1. Skin Ulcers 10.1.1.1.1. Diabetic Foot Ulcer - Stage I, Stage II, Stage III, Stage IV 10.1.1.1.2. Pressure Ulcer – Stage I, Stage II, Stage III, Stage IV 10.1.1.1.3. Venous Insufficiency - Stage I, Stage II, Stage III 10.1.1.1.4. Atherosclerosis – Stage I, Stage II, Stage III 10.1.2. Hair Care 10.1.2.1. Stage I 10.1.2.2. Stage II 10.1.2.3. Stage III 10.1.2.4. Stage IV 10.2. Orthopedic Surgery 10.2.1. Stage I 10.2.2. Stage II 10.2.3. Stage III 10.2.4. Stage IV 10.3. Ophthalmic Surgery 10.3.1. Stage I 10.3.2. Stage II 10.3.3. Stage III 10.3.4. Stage IV 10.4. Dentistry 10.4.1. Stage I 10.4.2. Stage II 10.4.3. Stage III 10.4.4. Stage IV 10.5. Cardiac Surgery 10.5.1. Stage I 10.5.2. Stage II 10.5.3. Stage III 10.5.4. Stage IV 10.6. Neurosurgery 10.6.1. Stage I 10.6.2. Stage II 10.6.3. Stage III 10.6.4. Stage IV 11. Platelet Rich Plasma Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 11.1. Physician's office/Private Practice 11.2. Hospitals 11.3. Orthopedic Clinics 11.4. Ophthalmic Clinics 11.5. Cosmetic/Dermatology/Trichology Clinics 11.6. Academic & Research Institutes 12. North America Platelet Rich Plasma Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. U.S.A 12.2.2. Canada 12.2.3. Mexico 12.3. Market Size (USD Million) Forecast for North America 2022-2028 13. Latin America Platelet Rich Plasma Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Brazil 13.2.2. Venezuela 13.2.3. Argentina 13.2.4. Rest of Latin America 13.3. Market Size (USD Million) Forecast for Latin America 2022-2028 14. Europe Platelet Rich Plasma Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Germany 14.2.2. U.K 14.2.3. France 14.2.4. Italy 14.2.5. Spain 14.2.6. Russia 14.2.7. Poland 14.2.8. Rest of Europe 14.3. Market Size (USD Million) Forecast for Europe 2022-2028 15. Asia Pacific Platelet Rich Plasma Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. Japan 15.2.2. China 15.2.3. India 15.2.4. Australia and New Zealand 15.2.5. ASEAN 15.2.6. Rest of Asia Pacific 15.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 16. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 16.1. Introduction 16.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 16.2.1. GCC 16.2.2. Israel 16.2.3. South Africa 16.2.4. Rest of MEA 16.3. Market Size (USD Million) Forecast for MEA 2022-2028 17. Market Share Analysis and Competitive Landscape 17.1. Global Landscape - Key Players, Revenue and Presence 17.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 17.3. Global Emerging Companies 17.4. North America - Market Share Analysis and Key Regional Players 17.5. Europe - Market Share Analysis and Key Regional Players 17.6. Asia Pacific - Market Share Analysis and Key Regional Players 17.7. Global Key Player - Growth Matrix 18. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 18.1. T-Biotechnology (T-LAB) 18.1.1. Company Overview 18.1.2. Product Portfolio 18.1.3. SWOT Analysis 18.1.4. Financial Overview 18.1.5. Strategic Overview 18.2. Arthrex, Inc. 18.2.1. Company Overview 18.2.2. Product Portfolio 18.2.3. SWOT Analysis 18.2.4. Financial Overview 18.2.5. Strategic Overview 18.3. Terumo BCT, Inc. 18.3.1. Company Overview 18.3.2. Product Portfolio 18.3.3. SWOT Analysis 18.3.4. Financial Overview 18.3.5. Strategic Overview 18.4. EmCyte Corporation 18.4.1. Company Overview 18.4.2. Product Portfolio 18.4.3. SWOT Analysis 18.4.4. Financial Overview 18.4.5. Strategic Overview 18.5. DePuy Synthes 18.5.1. Company Overview 18.5.2. Product Portfolio 18.5.3. SWOT Analysis 18.5.4. Financial Overview 18.5.5. Strategic Overview 18.6. Zimmer Biomet 18.6.1. Company Overview 18.6.2. Product Portfolio 18.6.3. SWOT Analysis 18.6.4. Financial Overview 18.6.5. Strategic Overview 18.7. Stryker 18.7.1. Company Overview 18.7.2. Product Portfolio 18.7.3. SWOT Analysis 18.7.4. Financial Overview 18.7.5. Strategic Overview 18.8. Glofinn Oy 18.8.1. Company Overview 18.8.2. Product Portfolio 18.8.3. SWOT Analysis 18.8.4. Financial Overview 18.8.5. Strategic Overview 18.9. DR. PRP AMERICA LLC 18.9.1. Company Overview 18.9.2. Product Portfolio 18.9.3. SWOT Analysis 18.9.4. Financial Overview 18.9.5. Strategic Overview 18.10.Johnson & Johnson 18.10.1. Company Overview 18.10.2. Product Portfolio 18.10.3. SWOT Analysis 18.10.4. Financial Overview 18.10.5. Strategic Overview 18.11. Exactech, Inc 18.11.1. Company Overview 18.11.2. Product Portfolio 18.11.3. SWOT Analysis 18.11.4. Financial Overview 18.11.5. Strategic Overview 18.12. Biotest Aktiengesellschaft 18.12.1. Company Overview 18.12.2. Product Portfolio 18.12.3. SWOT Analysis 18.12.4. Financial Overview 18.12.5. Strategic Overview 18.13. CSL Limited 18.13.1. Company Overview 18.13.2. Product Portfolio 18.13.3. SWOT Analysis 18.13.4. Financial Overview 18.13.5. Strategic Overview 19. Pre and Post COVID-19 Impact 19.1. Positive influence on the healthcare industry 19.2. The financial disruption of the manufacturing sector 19.3. Impact of COVID-19 on emerging companies 19.4. Significant mandates in the healthcare regulations initiated by administrations 19.5. The overall economic slowdown of the developing and developed nations 20. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders
2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study
3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights
4. Platelet Rich Plasma Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Platelet Rich Plasma Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Platelet Rich Plasma Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Platelet Rich Plasma Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Pure Platelet-rich Plasma 7.2. Leukocyte Platelet-rich Plasma 7.3. Pure Platelet-rich Fibrin 7.4. Leukocyte Platelet-rich Fibrin
8. Platelet Rich Plasma Market, By Origin Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Autologous Platelet-rich Plasma 8.2. Allogeneic Platelet-rich Plasma 8.3. Homologous Platelet-rich Plasma
9. Platelet Rich Plasma Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Cosmetic Surgery 9.1.1. Skin Care 9.1.2. Hair Care 9.2. Orthopedic Surgery 9.3. Ophthalmic Surgery 9.4. Dentistry 9.5. Cardiac Surgery 9.6. Neurosurgery 9.7. Other Indications
10. Platelet Rich Plasma Market, By Indication Stages Historical Analysis and Forecast 2022-2028 (USD Million) 10.1. Cosmetic Surgery 10.1.1. Skin Care - Stage I, Stage II, Stage III, Stage IV 10.1.1.1. Skin Ulcers 10.1.1.1.1. Diabetic Foot Ulcer - Stage I, Stage II, Stage III, Stage IV 10.1.1.1.2. Pressure Ulcer – Stage I, Stage II, Stage III, Stage IV 10.1.1.1.3. Venous Insufficiency - Stage I, Stage II, Stage III 10.1.1.1.4. Atherosclerosis – Stage I, Stage II, Stage III 10.1.2. Hair Care 10.1.2.1. Stage I 10.1.2.2. Stage II 10.1.2.3. Stage III 10.1.2.4. Stage IV 10.2. Orthopedic Surgery 10.2.1. Stage I 10.2.2. Stage II 10.2.3. Stage III 10.2.4. Stage IV 10.3. Ophthalmic Surgery 10.3.1. Stage I 10.3.2. Stage II 10.3.3. Stage III 10.3.4. Stage IV 10.4. Dentistry 10.4.1. Stage I 10.4.2. Stage II 10.4.3. Stage III 10.4.4. Stage IV 10.5. Cardiac Surgery 10.5.1. Stage I 10.5.2. Stage II 10.5.3. Stage III 10.5.4. Stage IV 10.6. Neurosurgery 10.6.1. Stage I 10.6.2. Stage II 10.6.3. Stage III 10.6.4. Stage IV
11. Platelet Rich Plasma Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 11.1. Physician's office/Private Practice 11.2. Hospitals 11.3. Orthopedic Clinics 11.4. Ophthalmic Clinics 11.5. Cosmetic/Dermatology/Trichology Clinics 11.6. Academic & Research Institutes
12. North America Platelet Rich Plasma Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. U.S.A 12.2.2. Canada 12.2.3. Mexico 12.3. Market Size (USD Million) Forecast for North America 2022-2028
13. Latin America Platelet Rich Plasma Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Brazil 13.2.2. Venezuela 13.2.3. Argentina 13.2.4. Rest of Latin America 13.3. Market Size (USD Million) Forecast for Latin America 2022-2028
14. Europe Platelet Rich Plasma Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Germany 14.2.2. U.K 14.2.3. France 14.2.4. Italy 14.2.5. Spain 14.2.6. Russia 14.2.7. Poland 14.2.8. Rest of Europe 14.3. Market Size (USD Million) Forecast for Europe 2022-2028
15. Asia Pacific Platelet Rich Plasma Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. Japan 15.2.2. China 15.2.3. India 15.2.4. Australia and New Zealand 15.2.5. ASEAN 15.2.6. Rest of Asia Pacific 15.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
16. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 16.1. Introduction 16.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 16.2.1. GCC 16.2.2. Israel 16.2.3. South Africa 16.2.4. Rest of MEA 16.3. Market Size (USD Million) Forecast for MEA 2022-2028
17. Market Share Analysis and Competitive Landscape 17.1. Global Landscape - Key Players, Revenue and Presence 17.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 17.3. Global Emerging Companies 17.4. North America - Market Share Analysis and Key Regional Players 17.5. Europe - Market Share Analysis and Key Regional Players 17.6. Asia Pacific - Market Share Analysis and Key Regional Players 17.7. Global Key Player - Growth Matrix
18. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 18.1. T-Biotechnology (T-LAB) 18.1.1. Company Overview 18.1.2. Product Portfolio 18.1.3. SWOT Analysis 18.1.4. Financial Overview 18.1.5. Strategic Overview 18.2. Arthrex, Inc. 18.2.1. Company Overview 18.2.2. Product Portfolio 18.2.3. SWOT Analysis 18.2.4. Financial Overview 18.2.5. Strategic Overview 18.3. Terumo BCT, Inc. 18.3.1. Company Overview 18.3.2. Product Portfolio 18.3.3. SWOT Analysis 18.3.4. Financial Overview 18.3.5. Strategic Overview 18.4. EmCyte Corporation 18.4.1. Company Overview 18.4.2. Product Portfolio 18.4.3. SWOT Analysis 18.4.4. Financial Overview 18.4.5. Strategic Overview 18.5. DePuy Synthes 18.5.1. Company Overview 18.5.2. Product Portfolio 18.5.3. SWOT Analysis 18.5.4. Financial Overview 18.5.5. Strategic Overview 18.6. Zimmer Biomet 18.6.1. Company Overview 18.6.2. Product Portfolio 18.6.3. SWOT Analysis 18.6.4. Financial Overview 18.6.5. Strategic Overview 18.7. Stryker 18.7.1. Company Overview 18.7.2. Product Portfolio 18.7.3. SWOT Analysis 18.7.4. Financial Overview 18.7.5. Strategic Overview 18.8. Glofinn Oy 18.8.1. Company Overview 18.8.2. Product Portfolio 18.8.3. SWOT Analysis 18.8.4. Financial Overview 18.8.5. Strategic Overview 18.9. DR. PRP AMERICA LLC 18.9.1. Company Overview 18.9.2. Product Portfolio 18.9.3. SWOT Analysis 18.9.4. Financial Overview 18.9.5. Strategic Overview 18.10.Johnson & Johnson 18.10.1. Company Overview 18.10.2. Product Portfolio 18.10.3. SWOT Analysis 18.10.4. Financial Overview 18.10.5. Strategic Overview 18.11. Exactech, Inc 18.11.1. Company Overview 18.11.2. Product Portfolio 18.11.3. SWOT Analysis 18.11.4. Financial Overview 18.11.5. Strategic Overview 18.12. Biotest Aktiengesellschaft 18.12.1. Company Overview 18.12.2. Product Portfolio 18.12.3. SWOT Analysis 18.12.4. Financial Overview 18.12.5. Strategic Overview 18.13. CSL Limited 18.13.1. Company Overview 18.13.2. Product Portfolio 18.13.3. SWOT Analysis 18.13.4. Financial Overview 18.13.5. Strategic Overview
19. Pre and Post COVID-19 Impact 19.1. Positive influence on the healthcare industry 19.2. The financial disruption of the manufacturing sector 19.3. Impact of COVID-19 on emerging companies 19.4. Significant mandates in the healthcare regulations initiated by administrations 19.5. The overall economic slowdown of the developing and developed nations
20. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics